DE69811236D1 - Ein brause-säure-basepaar enthaltende arzneimittel - Google Patents

Ein brause-säure-basepaar enthaltende arzneimittel

Info

Publication number
DE69811236D1
DE69811236D1 DE69811236T DE69811236T DE69811236D1 DE 69811236 D1 DE69811236 D1 DE 69811236D1 DE 69811236 T DE69811236 T DE 69811236T DE 69811236 T DE69811236 T DE 69811236T DE 69811236 D1 DE69811236 D1 DE 69811236D1
Authority
DE
Germany
Prior art keywords
product containing
acid base
medicinal product
effervescent
base couple
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69811236T
Other languages
English (en)
Other versions
DE69811236T2 (de
Inventor
Paolo Chiesi
Paolo Ventura
Rosa Mezzadri
Gaetano Brambilla
Daniela Acerbi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiesi Farmaceutici SpA
Original Assignee
Chiesi Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici SpA filed Critical Chiesi Farmaceutici SpA
Application granted granted Critical
Publication of DE69811236D1 publication Critical patent/DE69811236D1/de
Publication of DE69811236T2 publication Critical patent/DE69811236T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69811236T 1997-07-23 1998-07-23 Ein brause-säure-basepaar enthaltende arzneimittel Expired - Lifetime DE69811236T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI001746A IT1293764B1 (it) 1997-07-23 1997-07-23 Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua
PCT/EP1998/004517 WO1999004765A2 (en) 1997-07-23 1998-07-23 Pharmaceutical compositions containing an effervescent acid-base couple

Publications (2)

Publication Number Publication Date
DE69811236D1 true DE69811236D1 (de) 2003-03-13
DE69811236T2 DE69811236T2 (de) 2003-10-30

Family

ID=11377613

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69811236T Expired - Lifetime DE69811236T2 (de) 1997-07-23 1998-07-23 Ein brause-säure-basepaar enthaltende arzneimittel

Country Status (27)

Country Link
US (1) US6284272B1 (de)
EP (1) EP1003486B1 (de)
JP (1) JP4801255B2 (de)
KR (1) KR100528141B1 (de)
CN (1) CN1138535C (de)
AT (1) ATE232092T1 (de)
AU (1) AU743186B2 (de)
BG (1) BG64074B1 (de)
BR (1) BR9801335B1 (de)
CZ (1) CZ296221B6 (de)
DE (1) DE69811236T2 (de)
DK (1) DK1003486T3 (de)
EA (1) EA002608B1 (de)
ES (1) ES2191960T3 (de)
HK (1) HK1029525A1 (de)
HU (1) HU226115B1 (de)
IL (1) IL134166A (de)
IT (1) IT1293764B1 (de)
NO (1) NO326639B1 (de)
NZ (1) NZ502479A (de)
OA (1) OA10999A (de)
PL (1) PL199164B1 (de)
PT (1) PT1003486E (de)
SI (1) SI1003486T1 (de)
SK (1) SK284551B6 (de)
TR (1) TR199900675T1 (de)
WO (1) WO1999004765A2 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040151768A1 (en) * 1997-07-23 2004-08-05 Chiesi Farmaceutici S.P.A. Pharmaceutical compositions containing an effervescent acid-base couple
FR2786395A1 (fr) * 1998-12-01 2000-06-02 Virbac Sa Compositions seches solubles en presence d'eau et evitant la reaction de maillard a l'etat sec, leur preparation et leurs applications
CA2378525A1 (en) * 1999-07-02 2001-01-11 Sca Lohnherstellungs Ag A solid formulation of glucosamine sulphate
WO2001010405A1 (en) * 1999-08-04 2001-02-15 Ranbaxy Laboratories Limited Hydrodynamically balanced oral drug delivery system
IN190018B (de) * 1999-09-28 2003-05-31 Panacea Biotec Ltd
GB0006897D0 (en) * 2000-03-23 2000-05-10 Smithkline Beecham Plc Medicaments
CN1638739A (zh) * 2000-08-18 2005-07-13 法玛西雅厄普约翰美国公司 治疗成瘾性障碍的化合物
ATE329583T1 (de) * 2000-08-18 2006-07-15 Pharmacia Corp Schnell zerfallende orale arzneizubereitung enthaltend valdecoxib
US6531153B2 (en) * 2001-05-29 2003-03-11 Drugtech Corporation Composition with sustained release of levodopa and carbidopa
US6762153B2 (en) * 2001-10-18 2004-07-13 Rohm And Haas Company Delivery system for cyclopropenes
US20030091627A1 (en) * 2001-10-31 2003-05-15 Vinay Sharma Rate-controlled delivery of macrolides
KR100456273B1 (ko) * 2001-11-16 2004-11-10 김용년 산과 반응하여 일정 속도로 이산화탄소를 발생시킬 수있는 고상 제제 및 그의 제조 방법
US7488496B2 (en) * 2002-03-06 2009-02-10 Christer Rosen Effervescent compositions comprising bisphosphonates and methods related thereto
AU2003219999A1 (en) 2002-03-06 2003-09-22 Lifizz, Inc. Effervescent compositions comprising bisphosphonates and methods related thereto
BG730Y1 (bg) * 2003-03-20 2005-04-30 Владимир НАЙДЕНОВ Ефервесцентна лекарствена форма
CN100445263C (zh) * 2003-04-24 2008-12-24 四川大学 甘氨酸钠碳酸盐的微波合成方法
SI2260871T1 (sl) 2004-04-01 2013-09-30 Pierre Fabre Medicament Kompleksi sestavin, ki vključujejo piroksikam, ciklodekstrin in arginin
FR2876911B1 (fr) * 2004-10-21 2007-04-13 Pierre Fabre Medicament Sa Complexe comprenant du piroxicam, une cyclodextrine et de l'arginine
JP2008500288A (ja) * 2004-05-28 2008-01-10 イメイジノット ピーティーワイ エルティーディー 経口治療用化合物の供給系
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
US20070148238A1 (en) * 2005-06-23 2007-06-28 Spherics, Inc. Dosage forms for movement disorder treatment
CN100341488C (zh) * 2005-11-22 2007-10-10 瑞普（保定）生物药业有限公司 一种饮水免疫泡腾片及其制备方法
AU2006317530B2 (en) * 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
US20080131492A1 (en) * 2006-06-23 2008-06-05 Spherics, Inc. Dosage forms for movement disorder treatment
AU2007338631A1 (en) * 2006-12-22 2008-07-03 Combinatorx, Incorporated Pharmaceutical compositions for treatment of parkinson's disease and related disorders
EP2155159B1 (de) * 2007-05-08 2019-07-10 Hercules LLC Robuste tablettenformulierung mit schneller zersetzung
WO2009085306A1 (en) 2007-12-28 2009-07-09 Impax Laboratories, Inc. Controlled release formulations of levodopa and uses thereof
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
WO2010011522A1 (en) 2008-07-21 2010-01-28 Albemarle Corporation High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
ES2533030T3 (es) * 2010-03-13 2015-04-07 Eastpond Laboratories Limited Composiciones que enlazan grasa
CN101836951B (zh) * 2010-05-20 2013-06-05 山东达因海洋生物制药股份有限公司 一种含盐酸氨溴索的口服溶液及其制备方法
CN102322123B (zh) * 2011-06-30 2013-09-18 德清艺玛工艺装饰有限公司 一种仿大理石泡沫装饰材料
CN102398378A (zh) * 2011-11-03 2012-04-04 北京华禧联合科技发展有限公司 镀铬冲模在硫酸氢氯吡格雷片制备过程中的应用
CA2894272A1 (en) * 2012-12-14 2014-06-19 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
EP3054929B1 (de) 2013-10-07 2020-08-05 Impax Laboratories, LLC Mukoadhäsive levodopa-formulierungen mit gesteuerter freisetzung und/oder levodopa-ester und verwendungen davon
EP2870961B1 (de) * 2013-11-06 2018-07-18 Sanovel Ilac Sanayi ve Ticaret A.S. Brauseformulierungen von Pramipexol
US11844860B2 (en) 2018-03-02 2023-12-19 Chiesi Farmaceutici S.P.A. Pharmaceutical formulation for intraduodenal administration comprising melevodopa and carbidopa
US11986449B2 (en) 2020-12-22 2024-05-21 Amneal Pharmaceuticals Llc Levodopa dosing regimen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
EP0252290B1 (de) * 1986-06-10 1992-06-03 CHIESI FARMACEUTICI S.p.A. Levodopa-methyl-ester enthaltende pharmazeutische Zusammensetzungen, ihre Herstellung und therapeutische Verwendungen
CH675537A5 (de) * 1988-03-25 1990-10-15 Ciba Geigy Ag
DE3838431A1 (de) * 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen
DE69102900T3 (de) * 1990-02-14 1998-04-09 Otsuka Pharma Co Ltd Brausemischung, deren Herstellung sowie Verwendung.
US5252341A (en) * 1990-07-16 1993-10-12 Degussa Aktiengesellschaft Tablets and granulates containing mesna as active substance
JP2910425B2 (ja) * 1992-06-17 1999-06-23 和光純薬工業株式会社 発泡性錠剤の新規な製造方法
JP3170139B2 (ja) * 1994-04-08 2001-05-28 エスエス製薬株式会社 発泡性錠剤
FR2733420B1 (fr) * 1995-04-28 1997-06-27 Sep Tarral Preparations pectiques utilisables comme support de medicament
AU712710B2 (en) * 1996-05-17 1999-11-11 Merck Sharp & Dohme Corp. Effervescent bisphosphonate formulation

Also Published As

Publication number Publication date
HK1029525A1 (en) 2001-04-06
AU743186B2 (en) 2002-01-17
HUP0003897A3 (en) 2006-06-28
WO1999004765A3 (en) 1999-06-10
JP2001510789A (ja) 2001-08-07
ITMI971746A1 (it) 1999-01-23
OA10999A (en) 2001-11-07
PL338502A1 (en) 2000-11-06
BR9801335B1 (pt) 2010-09-21
ATE232092T1 (de) 2003-02-15
BR9801335A (pt) 1999-05-04
DK1003486T3 (da) 2003-05-19
KR100528141B1 (ko) 2005-11-15
AU8977798A (en) 1999-02-16
IL134166A (en) 2005-08-31
EP1003486B1 (de) 2003-02-05
CN1138535C (zh) 2004-02-18
BG103253A (en) 1999-09-30
HU226115B1 (en) 2008-04-28
NO991376L (no) 1999-05-25
SI1003486T1 (en) 2003-08-31
NO326639B1 (no) 2009-01-26
NO991376D0 (no) 1999-03-22
CZ2000255A3 (cs) 2000-07-12
CZ296221B6 (cs) 2006-02-15
US6284272B1 (en) 2001-09-04
WO1999004765A2 (en) 1999-02-04
SK922000A3 (en) 2000-07-11
DE69811236T2 (de) 2003-10-30
CN1267215A (zh) 2000-09-20
IT1293764B1 (it) 1999-03-10
NZ502479A (en) 2002-02-01
KR20010022140A (ko) 2001-03-15
EA002608B1 (ru) 2002-06-27
BG64074B1 (bg) 2003-12-31
EP1003486A2 (de) 2000-05-31
PT1003486E (pt) 2003-06-30
SK284551B6 (sk) 2005-06-02
EA200000062A1 (ru) 2000-10-30
IL134166A0 (en) 2001-04-30
HUP0003897A2 (hu) 2001-08-28
TR199900675T1 (xx) 1999-11-22
JP4801255B2 (ja) 2011-10-26
ES2191960T3 (es) 2003-09-16
PL199164B1 (pl) 2008-08-29

Similar Documents

Publication Publication Date Title
DE69811236D1 (de) Ein brause-säure-basepaar enthaltende arzneimittel
TWI235068B (en) Sustained-release pharmaceutical composition
DE69626117D1 (de) Orale pharmazeutische zusammensetzungen mit verzögerter freisetzung von reversiblen protonpumpen-inhibitoren
LV11984A (lv) Farmaceitiska kompozicija putojosa dzeriena pagatavosanai
MY125766A (en) Flash-melt oral dosage formulation
CA2396159A1 (en) Novel substituted benzimidazole dosage forms and method of using same
BR0007294A (pt) Formulações farmacêuticas aperfeiçoadas
GB2295966B (en) Direct compression tablets
CA2386423A1 (en) Pharmaceutical compositions containing copper, salicylic acid and vitamines c
CA2297673A1 (en) Pharmaceutical compositions containing an effervescent acid-base couple
JO1881B1 (en) Formula II for multi unit disc calibration

Legal Events

Date Code Title Description
8364 No opposition during term of opposition